The DSIP peptide for sleep regulation research targets the neuroendocrine pathways governing circadian rhythm and cortisol timing. Here is how delta sleep-inducing peptide crosses the blood-brain barrier and what it does there.
Delta sleep-inducing peptide (DSIP) research focuses on the neuroendocrine pathways governing circadian rhythms. Isolated in 1974, this nonapeptide has a broad regulatory profile that differentiates it from simple sedative or hypnotic compounds.
DSIP does not act via a single receptor. Instead, it normalizes the HPA axis, modulates cortisol/ACTH timing, and impacts growth hormone release patterns. DSIP neuroendocrine research in the European Journal of Pharmacology documented these multi-system effects.
Unlike many peptides, DSIP crosses the blood-brain barrier intact after peripheral administration. This is facilitated by a saturable transport mechanism and the peptide's unique conformational properties, allowing researchers to observe centrally mediated effects via systemic injection.
DSIP research consistently shows the normalization of cortisol rhythms in stress models. Rather than simple suppression, the compound helps restore the appropriate high-morning, low-evening timing that characterizes healthy baseline function. Beyond Health Lab supplies DSIP 5mg at ≥99% verified purity.
Join 10,000+ researchers. Get your discount code, early access to new compounds, and protocol insights.
No spam, ever. Unsubscribe anytime.
Check your inbox for your discount code.
Here's a preview:
Valid on all products · Single use
